Senior Director, Global HTA Value & Evidence, Medical Dermatology

Multiple locations, US.

This position will be part of Pfizer’s dynamic Global Access & Value (GAV) team and will have the important role of managing health economics and outcomes research (HEOR) to lead and oversee evidence generation to support patient access to our therapies, with a primary focus on dermatology.  This position will be working closely with the GAV cross-functional and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and healthcare.

ROLE RESPONSIBILITIES

• Proactively lead the development of the Global HTA evidence generation strategy to support the holistic value of priority dermatologic indications in close partnership with the cross-functional matrix team.
• Demonstrate technical mastery and proactively identify and address methodological issues that may affect health economics and outcomes research to support Pfizer products.
• Provide oversight of external consultants and independent experts supporting the med derm teams
• Drive best practice sharing across the team in support of strategy development and deepening team skills and competencies.
• Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the evidence strategy to support global market access needs at launch and through lifecycle.
• Participate in key cross-divisional task forces to help improve processes and standards in HV&E programs.
• Lead and supervise the design and execution of global HEOR studies (e.g., network meta-analyses, non-interventional studies) from concept through publication, working with agility to meet critical deadlines. 
• Lead and supervise the timely development of launch deliverables including Value & Evidence Strategy, global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.
• Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements. Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) and analysis to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
• Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
• Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Graduate degree minimum required (e.g. MSc, MPH, PhD) required, postgraduate degree preferred
• 13+ years of experience required with MSc/MPH/MBA degree; 10+ years of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
• Demonstrated in-depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis, and interpretation.
• HEOR experience in the immunology therapeutic area
• Demonstrated HEOR performance in high-quality high-speed dynamic work environment
• Demonstrated agility to meet deadlines under pressure, accelerated timelines, and constrained resources
• Experience with HTA organizations such as NICE, CDA (formerly CADTH), PBAC, ICER, and other HTA groups
• Capable of independently managing complex non-interventional study projects
• Knowledge and understanding of drug-development process
• Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
• Excellent oral and written English communication skills
• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• An “execution mindset” focused on getting things done quickly and simply
• Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
• Ability to influence key members of medical, clinical, and commercial teams constructively and without conflict
• Skilled in functioning within a matrix organization where managing through influence
• Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address/resolve
• Change oriented, comfortable responding to unexpected demands with tight timelines; team player

PREFERRED QUALIFICATIONS

• Knowledge and experience in early drug development and commercialization.
• Direct experience leading others (direct management or matrix leadership), with strong track record of high level of stakeholder engagement and delivering results through oversight
• Excellent interpersonal skills: ability to understand and respond to multiple internal and external customers; build strategic partnerships internally and externally

NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS

• Ability to travel domestically and internationally based on business needs
• Ability to work in all US time zones

ORGANIZATIONAL RELATIONSHIPS

• The primary groups that this role will interact with as a regular part of the role responsibilities are GASP, Statistician, Scientific Affairs, Medical Affairs, POL, Clinical Scientist.

RESOURCES MANAGED

• Expected to collaborate with over 25 indirect reports and 1-2 direct reports (mainly consultants across the team). No revenue accountability.

OTHER INFORMATION:

• Last Date to Apply for Job: October 25th, 2024
• Eligible for employee referral bonus
• NOT Eligible for Relocation Package
• Position is hybrid and will require 2 to 3 days a week to work from site

This job ad will be unpublished on 26/10/2024.

This job is posted by Pfizer.

APPLY FOR JOB

This link brings you to the website of Pfizer.

Please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!